Skip to content
Green ArkSign in
Journal

What The Lawyers Say

1,101 posts by 291 firms and lawyers

Cannabis law explained by the lawyers who practise it: analysis and commentary from law firms around the world, with the Cannabis Law Journal.

81 posts

JA Kemp

26 March 2026 – How the EU is re-shaping the regulation of gene-edited plants

Upcoming changes to European Union legislation will significantly alter the regulation of gene-edited crops. This article outlines the main trends of the EU’s new framework for plants obtained by New Genomic Techniques (NGTs),…

Bradley Arant Boult Cummings

How Will the Cannabis World Look When Marijuana Is Rescheduled?

” I thought about responding with a quote from “Run Like an Antelope” but then it hit me: Maybe we should give some thought to a more high-minded discussion about the practical implications of marijuana rescheduling. ) So, I…

Elijah Hartman, Harris Sliwoski

Cannabis Branding and Trademark Protection

This would be a good time to review the branding protection avenues available to cannabis business owners, and to discuss celebrity branding.

Harris Sliwoski

Florida’s Cannabis and Hemp Landscape: Key Regulatory Changes to Watch

Florida’s cannabis and hemp industries are undergoing significant regulatory shifts. From proposed legislation targeting hemp products to new rules affecting packaging and labeling, here’s what you need to know about the latest…

Lloyd & Mousill

What Is The USPTO Doing About Hemp-derived Delta-8 THC?

Delta-8 THC is a cannabinoid found in cannabis. The natural quantities of delta-8 found in cannabis are pretty low, so to create usable amounts of it, it typically has be synthesized from hemp.

CMS

Cannabis Law And Legislation In China

CMS is a Future Facing organisation of independent law firms. With 84 offices in over 47 countries and 5,800+ lawyers worldwide, we combine deep local market understanding with a global overview, giving us the ability not only to…

Clark Hill

Leveraging and Protecting Cannabis Brands Following CSA Rescheduling

This is an exciting time for cannabis entrepreneurs as the US government is poised to reclassify cannabis as a Schedule III drug in a move that recognizes cannabis’ medical and therapeutic uses and may open the door for new…

Marks & Clerk

Gene Editing (Plants) And EU Regulations – A Patent Attorney’s Perspective

Marks & Clerk Via Mondaq Ten years ago gene editing plants was far from commonplace – indeed, the first CRISPR edited mammalian cells had only just been achieved. Fast-forward ten years and a search for gene edited crops lists…

Finnegan

Breeders’ Rights No Longer A Pipe Dream For New Marijuana Varieties?

The cannabis industry may be on the brink of a significant shift in intellectual property protection for new marijuana varieties. With the recent announcement by the U.S. Attorney General to initiate proceedings to transfer…

20 of 81

Firms

290
All 290 firms